FDA
Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world
July 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan
The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …
Top Ten most popular articles on Pharmafile.com this week!
July 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma
On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …
FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections
July 18, 2019Sales and Marketing FDA, MSD, Recarbrio, US, pharma, urinary tract
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment …
Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients
July 16, 2019Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma
The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.
FDA and EMA fully implement mutual recognition agreement between US and EU
July 15, 2019Sales and Marketing EMA, FDA, GMP, Slovakia, mra, mutual recognition, pharma
The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties. The recognition of Slovakia marks the full …
AstraZeneca’s Farxiga fails to get FDA approval for patients with Type 1 diabetes
July 15, 2019Sales and Marketing AstraZeneca, EMA, FDA, US, diabetes, farxiga
The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in …
FDA sharpen focus on pharmaceutical companies under Trump
July 5, 2019Medical Communications FDA, Obama, Trump, USA, pharma, regulation
The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …
FDA approves multiple myeloma therapy Xpovio despite safety concerns
July 4, 2019Sales and Marketing FDA, Karyopharm, Xpovio, multiple myeloma, pharma
The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …
Elizabeth Warren calls on former FDA commissioner Scott Gottlieb to resign from board of Pfizer
July 2, 2019Research and Development FDA, Pfizer, Scott Gottlieb, health, pharma, public health
Democrat Presidential candidate Elizabeth Warren has criticised Scott Gottlieb for joining Pfizer. In a letter to Gottlieb, Senator Warren …
Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors
June 28, 2019Medical Communications FDA, Pfizer, Scott Gottlieb, pharma
Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …
FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis
June 27, 2019Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis
Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …
FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris
June 25, 2019Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma
Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …
FDA expands Vertex’s cystic fibrosis drug Symdeko in paediatric patients
June 24, 2019Sales and Marketing FDA, Symdeko, Vertex, cystic fibrosis, pharma
Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko …
FDA approve libido enhancing drug for women with low sexual desire
June 24, 2019Sales and Marketing FDA, HSDD, health, pharma, viagra, vyleesi
The FDA has approved a new drug for women with low libido.The FDA has approved AMAG Pharmaceuticals’ bremelanotide – sold …
Top Ten most popular articles on Pharmafile.com this week
June 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten
It’s Friday, and time for another run-down of the week’s most popular articles.
Latest content
Five Facts about cardiovascular disease
